ea0088002 | Abstracts | BES2022
Hulle F Van
, Groot K De
, R Hilbrands
, de Velde U Van
, K Suenens
, G Stange
, Mesmaeker I De
, Paep DL De
, Z Ling
, B Roep
, P Gillard
, D Pipeleers
, B Keymeulen
, Tulleneers-Thevissen D Jacobs-
Introduction: Intraportal (IP) islet cell transplants can restore metabolic control in type 1 diabetes patients, but limitations raise the need for establishing a functional beta cell mass (FBM) in a confined extrahepatic site.Methods: This study reports on function and composition of omental (OM) implants after placement of islet cell grafts with similar beta cell mass as in our IP-protocol (25.106 beta cells/kg body weight)<p class...